These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [A clinical analysis of twenty-five cases of eosinophilic lung disease]. Liang Q; Chen Y; Kong J; Pan Y Zhonghua Nei Ke Za Zhi; 2015 May; 54(5):426-30. PubMed ID: 26080822 [TBL] [Abstract][Full Text] [Related]
3. Chronic eosinophilic pneumonitis due to the inhalation of aerosolized face lotion: A case report. Shimoda M; Morimoto K; Tanaka Y; Takemura T; Oka T; Yoshimori K; Ken O Medicine (Baltimore); 2021 May; 100(19):e25860. PubMed ID: 34106632 [TBL] [Abstract][Full Text] [Related]
4. A benefit-risk assessment of benzbromarone in the treatment of gout. Was its withdrawal from the market in the best interest of patients? Lee MH; Graham GG; Williams KM; Day RO Drug Saf; 2008; 31(8):643-65. PubMed ID: 18636784 [TBL] [Abstract][Full Text] [Related]
15. A randomised controlled trial on the efficacy and tolerability with dose escalation of allopurinol 300-600 mg/day versus benzbromarone 100-200 mg/day in patients with gout. Reinders MK; Haagsma C; Jansen TL; van Roon EN; Delsing J; van de Laar MA; Brouwers JR Ann Rheum Dis; 2009 Jun; 68(6):892-7. PubMed ID: 18633127 [TBL] [Abstract][Full Text] [Related]
16. [Positive response to smoking challenge test in a case of acute eosinophilic pneumonia]. Ito S; Taniguchi H; Kondo Y; Mizuno Y; Nishiyama O; Wakayama H; Nakagawa T; Hayashi H; Yamaki K Nihon Kokyuki Gakkai Zasshi; 1999 May; 37(5):424-8. PubMed ID: 10410548 [TBL] [Abstract][Full Text] [Related]